AT321063T - new immunoeffectorverbindungen - Google Patents

new immunoeffectorverbindungen

Info

Publication number
AT321063T
AT321063T AT01959445T AT01959445T AT321063T AT 321063 T AT321063 T AT 321063T AT 01959445 T AT01959445 T AT 01959445T AT 01959445 T AT01959445 T AT 01959445T AT 321063 T AT321063 T AT 321063T
Authority
AT
Austria
Prior art keywords
immunoeffectorverbindungen
new
Prior art date
Application number
AT01959445T
Other languages
German (de)
Inventor
David A Johnson
Jory Baldridge
C Gregory Sowell
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22305600P priority Critical
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AT321063T publication Critical patent/AT321063T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
AT01959445T 2000-08-04 2001-08-03 new immunoeffectorverbindungen AT321063T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US22305600P true 2000-08-04 2000-08-04

Publications (1)

Publication Number Publication Date
AT321063T true AT321063T (en) 2006-04-15

Family

ID=22834828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01959445T AT321063T (en) 2000-08-04 2001-08-03 new immunoeffectorverbindungen

Country Status (9)

Country Link
US (2) US7129219B2 (en)
EP (1) EP1311522B1 (en)
JP (1) JP4843181B2 (en)
AT (1) AT321063T (en)
AU (2) AU2001281001B2 (en)
CA (1) CA2417806C (en)
DE (1) DE60118207T2 (en)
ES (1) ES2261453T3 (en)
WO (1) WO2002012258A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100858947B1 (en) 2002-02-04 2008-09-17 코릭사 코포레이션 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US6525028B1 (en) 2002-02-04 2003-02-25 Corixa Corporation Immunoeffector compounds
US6911434B2 (en) 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
CA2474398A1 (en) * 2002-02-04 2003-08-14 Corixa Corporation New immunoeffector compounds
US7288640B2 (en) 2002-07-08 2007-10-30 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
AU2003251824B8 (en) * 2002-07-08 2010-08-05 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
US7960522B2 (en) 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
HUE026376T2 (en) 2003-01-06 2016-05-30 Corixa Corp Certain aminoalkyl glucosaminide phosphate compounds and their use
US7998930B2 (en) * 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
PT1968631E (en) 2005-12-22 2015-07-20 Glaxosmithkline Biolog Sa Vaccine
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
KR20100045445A (en) 2007-06-26 2010-05-03 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
GB201101331D0 (en) 2011-01-26 2011-03-09 Glaxosmithkline Biolog Sa Compositions and uses
HUE037408T2 (en) 2011-06-10 2018-08-28 Univ Oregon Health & Science Cmv glycoproteins and recombinant vectors
GB201113570D0 (en) 2011-08-05 2011-09-21 Glaxosmithkline Biolog Sa Vaccine
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (en) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Env-glycoprotein variant of HIV-1
CN105188710A (en) 2013-03-15 2015-12-23 葛兰素史密丝克莱恩生物有限公司 Composition containing buffered aminoalkyl glucosaminide phosphate derivatives and its use for enhancing an immune response
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US20170071967A1 (en) 2014-03-12 2017-03-16 Glaxosmithkline Biologicals, Sa Immunogenic liposomal formulation
US20170072033A1 (en) 2014-03-12 2017-03-16 Glaxosmithkline Biologicals, Sa Liposomal compositions for mucosal delivery
KR20180002593A (en) 2015-01-28 2018-01-08 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Efficacy ICOS binding protein
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
TW201716084A (en) 2015-08-06 2017-05-16 Glaxosmithkline Ip Dev Ltd Therapeutic compositions and uses
US20180221399A1 (en) 2015-08-06 2018-08-09 Glaxosmithkline Intellectual Property Development TLR4 agonists and compositions thereof and their use in the treatment of cancer
WO2017021912A1 (en) 2015-08-06 2017-02-09 Glaxosmithkline Intellectual Property Development Limited Combined tlrs modulators with anti ox40 antibodies
CN107849084A (en) 2015-12-03 2018-03-27 葛兰素史密斯克莱知识产权发展有限公司 Cyclic purine dinucleotides as modulators of sting
WO2017098421A1 (en) 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Benzothiadiazine compounds
WO2017112797A1 (en) * 2015-12-22 2017-06-29 Thomas Jefferson University Intra-lesional cmv-based cancer vaccines
WO2017153952A1 (en) 2016-03-10 2017-09-14 Glaxosmithkline Intellectual Property Development Limited 5-sulfamoyl-2-hydroxybenzamide derivatives
EP3440076A1 (en) 2016-04-07 2019-02-13 GlaxoSmithKline Intellectual Property Development Ltd Heterocyclic amides useful as protein modulators
AU2017247806A1 (en) 2016-04-07 2018-11-08 Glaxosmithkline Intellectual Property Development Limited Heterocyclic amides useful as protein modulators
CN109328188A (en) 2016-05-05 2019-02-12 葛兰素史密斯克莱知识产权(第2 号)有限公司 2 inhibitor of ZESTE enhancer homologue
US20190241573A1 (en) 2016-07-20 2019-08-08 Glaxosmithkline Intellectual Property Development Limited Isoquinoline derivatives as perk inhibitors
CN110225983A (en) 2016-12-01 2019-09-10 葛兰素史密斯克莱知识产权发展有限公司 The method for the treatment of cancer
WO2019021208A1 (en) 2017-07-27 2019-01-31 Glaxosmithkline Intellectual Property Development Limited Indazole derivatives useful as perk inhibitors
WO2019053617A1 (en) 2017-09-12 2019-03-21 Glaxosmithkline Intellectual Property Development Limited Chemical compounds
WO2019069269A1 (en) 2017-10-05 2019-04-11 Glaxosmithkline Intellectual Property Development Limited Modulators of stimulator of interferon genes (sting) useful in treating hiv
WO2019069270A1 (en) 2017-10-05 2019-04-11 Glaxosmithkline Intellectual Property Development Limited Modulators of stimulator of interferon genes (sting)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113918A (en) * 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6013640A (en) * 1998-08-21 2000-01-11 Ribi Immunochem Research, Inc. Phosphoglycolipid and methods for its use
US6911434B2 (en) * 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US6525028B1 (en) * 2002-02-04 2003-02-25 Corixa Corporation Immunoeffector compounds

Also Published As

Publication number Publication date
DE60118207T2 (en) 2006-11-09
JP4843181B2 (en) 2011-12-21
US20040132988A1 (en) 2004-07-08
US20070004914A1 (en) 2007-01-04
AU2001281001B2 (en) 2005-11-03
CA2417806A1 (en) 2002-02-14
US7501399B2 (en) 2009-03-10
AU8100101A (en) 2002-02-18
US7129219B2 (en) 2006-10-31
EP1311522B1 (en) 2006-03-22
CA2417806C (en) 2011-05-10
WO2002012258A1 (en) 2002-02-14
DE60118207D1 (en) 2006-05-11
ES2261453T3 (en) 2006-11-16
EP1311522A4 (en) 2004-06-09
JP2004505986A (en) 2004-02-26
EP1311522A1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
DE60112945D1 (en) Schädelkalottenfixiereinrichtung
DE60116715D1 (en) Ablationskartierungskatheter
DE60131628D1 (en) Stenteinführvorrichtung
DE60140253D1 (en) Oreinheit
DE60130536D1 (en) Analytensensor
DE60110402D1 (en) Strukturverbaupanele
DE60142973D1 (en) Enstrukturen
DE60129698D1 (en) Thrombinrezeptorantagonisten
DE60142394D1 (en) Biozensor
DE60132227D1 (en) Tintenstrahlaufzeichungsmaterial
DE60113289D1 (en) Schergelzusammensetzungen
DE50107313D1 (en) Lichtleitfaserverbindungsgehäuse
DE60112184D1 (en) Ejektorzyklus
DE60140330D1 (en) Mikrokontaktprüfnadel
DE50111625D1 (en) Seitenblinkleuchte
DE60121343D1 (en) Lotterielosaktionsspiel
DE60142618D1 (en) Polysulfonamidmatrizen
DE60142211D1 (en) Graben - schottkygleichrichter
DE60116635D1 (en) Flüssigkeitssprühgeräte
DE60043512D1 (en) Epoxyalkoxysiloxanoligomere
DE60143960D1 (en) Äuren
DE60142614D1 (en) Inität
DE60138702D1 (en) 2-aminocarbonyl-9h-purinderivative
DE60118634D1 (en) Biodatenschnittstellensystem
DE60128207D1 (en) Angioplastievorrichtunng

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties